Clinical trial

Empagliflozin in Acute Heart Failure

NCT05305495

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-12-22

PhasePHASE4

Study timeline

Study start (actual)2022-12-22Date precision: day

Registry last updated2026-03-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Acute Heart Failureunresolved

Chronic Kidney Diseasesunresolved

Interventions

Empagliflozin 25 MGDRUG

Sponsors & collaborators

McGill University Health Centre/Research Institute of the McGill University Health Centrelead sponsor

Mapped research locations

MontrealQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05305495 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.